Research Output per year
Research Output
2020
ADAM10 and ADAM17 cleave PD-L1 to mediate PD-(L)1 inhibitor resistance
Orme, J. J., Jazieh, K. A., Xie, T., Harrington, S., Liu, X., Ball, M., Madden, B., Charlesworth, M. C., Azam, T. U., Lucien, F., Wootla, B., Li, Y., Villasboas, J. C., Mansfield, A. S., Dronca, R. S. & Dong, H., Jan 1 2020, In : OncoImmunology. 9, 1, 1744980.Research output: Contribution to journal › Article
Open Access
Impact of MYD88L265P mutation status on histological transformation of Waldenström Macroglobulinemia
Zanwar, S., Abeykoon, J. P., Durot, E., King, R., Perez Burbano, G. E., Kumar, S., Gertz, M. A., Quinquenel, A., Delmer, A., Gonsalves, W., Cornillet-Lefebvre, P., He, R., Warsame, R., Buadi, F. K., Novak, A. J., Greipp, P. T., Inwards, D., Habermann, T. M., Micallef, I., Go, R. & 19 others, , Mar 1 2020, In : American journal of hematology. 95, 3, p. 274-281 8 p.Research output: Contribution to journal › Article
1
Scopus
citations
Mass cytometry identifies expansion of double positive and exhausted T cell subsets in the tumour microenvironment of patients with POEMS syndrome
Kourelis, T. V., Jevremovic, D., Jessen, E., Dasari, S., Villasboas, J. C., Dispenzieri, A. & Kumar, S., Jan 1 2020, (Accepted/In press) In : British journal of haematology.Research output: Contribution to journal › Article
Multi-site reproducibility of a human immunophenotyping assay in whole blood and peripheral blood mononuclear cells preparations using CyTOF technology coupled with Maxpar Pathsetter, an automated data analysis system
Bagwell, C. B., Hunsberger, B., Hill, B., Herbert, D., Bray, C., Selvanantham, T., Li, S., Villasboas, J. C., Pavelko, K., Strausbauch, M., Rahman, A., Kelly, G., Asgharzadeh, S., Gomez-Cabrero, A., Behbehani, G., Chang, H., Lyberger, J., Montgomery, R., Zhao, Y., Inokuma, M. & 2 others, , Mar 1 2020, In : Cytometry Part B - Clinical Cytometry. 98, 2, p. 146-160 15 p.Research output: Contribution to journal › Article
2
Scopus
citations
2019
Autograft immune content and survival in non-Hodgkin's lymphoma: A post hoc analysis
Porrata, L. F., Inwards, D. J., Ansell, S. M., Micallef, I. N., Johnston, P. B., Villasboas, J. C. & Markovic, S. N., Jun 2019, In : Leukemia Research. 81, p. 1-9 9 p.Research output: Contribution to journal › Article
1
Scopus
citations
Mass Cytometry Analysis Reveals that Specific Intratumoral CD4 + T Cell Subsets Correlate with Patient Survival in Follicular Lymphoma
Yang, Z. Z., Kim, H. J., Villasboas, J. C., Price-Troska, T., Jalali, S., Wu, H., Luchtel, R. A., Polley, M. Y. C., Novak, A. J. & Ansell, S. M., Feb 19 2019, In : Cell reports. 26, 8, p. 2178-2193.e3Research output: Contribution to journal › Article
Open Access
11
Scopus
citations
Mass cytometry dissects T cell heterogeneity in the immune tumor microenvironment of common dysproteinemias at diagnosis and after first line therapies
Kourelis, T., Villasboas Bisneto, J. J. C. ., Jessen, E., Dasari, S., Dispenzieri, A., Jevremovic, D. & Kumar, S. K., Sep 1 2019, In : Blood cancer journal. 9, 9, 72.Research output: Contribution to journal › Article
Open Access
4
Scopus
citations
Practical limitations of monocyte subset repartitioning by multiparametric flow cytometry in chronic myelomonocytic leukemia
Pophali, P. A., Timm, M. M., Mangaonkar, A. A., Shi, M., Reichard, K., Tefferi, A., Pavelko, K., Villasboas Bisneto, J. J. C. ., Jevremovic, D. & Patnaik, M. M., Sep 1 2019, In : Blood cancer journal. 9, 9, 65.Research output: Contribution to journal › Letter
Open Access
3
Scopus
citations
Reverse signaling via PD-L1 supports malignant cell growth and survival in classical Hodgkin lymphoma
Jalali, S., Price-Troska, T., Bothun, C., Villasboas Bisneto, J. J. C. ., Kim, H. J., Yang, Z. Z., Novak, A. J., Dong, H. M. & Ansell, S. M., Mar 1 2019, In : Blood cancer journal. 9, 3, 22.Research output: Contribution to journal › Article
6
Scopus
citations
SIRPα expression delineates subsets of intratumoral monocyte/macrophages with different functional and prognostic impact in follicular lymphoma
Chen, Y. P., Kim, H. J., Wu, H., Price-Troska, T., Villasboas, J. C., Jalali, S., Feldman, A. L., Novak, A. J., Yang, Z. Z. & Ansell, S. M., Oct 1 2019, In : Blood cancer journal. 9, 10, 84.Research output: Contribution to journal › Article
Open Access
1
Scopus
citations
The utility of prognostic indices, early events, and histological subtypes on predicting outcomes in non-follicular indolent B-cell lymphomas
Tracy, S. I., Larson, M. C., Feldman, A. L., Maurer, M. J., Novak, A. J., Slager, S. L., Villasboas Bisneto, J. J. C. ., Allmer, C., Habermann, T. M., Farooq, U., Syrbu, S., Cerhan, J. R. & Link, B. K., Jun 1 2019, In : American journal of hematology. 94, 6, p. 658-666 9 p.Research output: Contribution to journal › Article
3
Scopus
citations
2018
Next-generation immunotherapy in Lymphoma: Checkpoint blockade, chimeric antigen receptor T cells, and beyond
Villasboas Bisneto, J. J. C. ., Jan 5 2018, The Basics of Cancer Immunotherapy. Springer International Publishing, p. 95-114 20 p.Research output: Chapter in Book/Report/Conference proceeding › Chapter
Soluble PD-1 ligands regulate T-cell function in Waldenstrom macroglobulinemia
Jalali, S., Price-Troska, T., Paludo, J., Villasboas, J., Kim, H. J., Yang, Z. Z., Novak, A. J. & Ansell, S. M., Aug 14 2018, In : Blood Advances. 2, 15, p. 1985-1997 13 p.Research output: Contribution to journal › Article
Open Access
7
Scopus
citations
2017
Expression of LAG-3 defines exhaustion of intratumoral PD-1+ T cells and correlates with poor outcome in follicular lymphoma
Yang, Z. Z., Kim, H. J., Villasboas Bisneto, J. J. C. ., Chen, Y. P., Price-Troska, T. P., Jalali, S., Wilson, M., Novak, A. J. & Ansell, S. M., Sep 1 2017, In : Oncotarget. 8, 37, p. 61425-61439 15 p.Research output: Contribution to journal › Article
21
Scopus
citations
Targeted Approaches Applied to Uncommon Diseases: A Case of Salivary Duct Carcinoma Metastatic to the Brain Treated with the Multikinase Inhibitor Neratinib
Sorenson, K. R., Piovezani Ramos, G., Villasboas Bisneto, J. C. & Price, K., May 5 2017, In : Case Reports in Oncology. 10, 2, p. 726-731 6 p.Research output: Contribution to journal › Article
1
Scopus
citations
2016
A proof-of-concept trial of protein kinase C iota inhibition with auranofin for the paclitaxel-induced acute pain syndrome
Jatoi, A., Grudem, M. E., Dockter, T. J., Block, M. S., Villasboas Bisneto, J. J. C. ., Tan, A., Deering, E., Kasi, P. M., Mansfield, A., Botero, J. P., Okuno, S. H., Smith, D. R. & Fields, A. P., Nov 12 2016, (Accepted/In press) In : Supportive Care in Cancer. p. 1-6 6 p.Research output: Contribution to journal › Article
4
Scopus
citations
Checkpoint inhibition: Programmed cell death 1 and programmed cell death 1 ligand inhibitors in Hodgkin lymphoma
Villasboas Bisneto, J. J. C. . & Ansell, S. M., Jan 1 2016, In : Cancer Journal (United States). 22, 1, p. 17-22 6 p.Research output: Contribution to journal › Article
14
Scopus
citations
Clinical Presentation and Diagnostic Challenges of Thyroid Lymphoma: A Cohort Study
Sharma, A., Jasim, S., Reading, C. C., Ristow, K. M., Villasboas Bisneto, J. J. C. ., Habermann, T. M., Fatourechi, V. & Stan, M., Aug 1 2016, In : Thyroid. 26, 8, p. 1061-1067 7 p.Research output: Contribution to journal › Article
17
Scopus
citations
Glancing at the complex biology of T-cells through the microenvironment of Hodgkin lymphoma*
Villasboas Bisneto, J. J. C. . & Ansell, S. M., Oct 28 2016, (Accepted/In press) In : Leukemia and Lymphoma. p. 1-3 3 p.Research output: Contribution to journal › Article
1
Scopus
citations
Initial presentation of CNS-restricted acute lymphoblastic B cell leukaemia as peripheral polyneuropathy
Ramos, G. P., Villasboas Bisneto, J. J. C. ., Chen, D. & Pardanani, A. D., Apr 19 2016, In : BMJ Case Reports. 2016, 600.Research output: Contribution to journal › Article
Nivolumab for the treatment of classical Hodgkin lymphoma after failure of autologous stem cell transplant and brentuximab
Villasboas Bisneto, J. J. C. . & Ansell, S. M., Jan 2 2016, In : Expert Review of Anticancer Therapy. 16, 1, p. 5-12 8 p.Research output: Contribution to journal › Article
11
Scopus
citations
Recent advances in the management of Hodgkin lymphoma
Villasboas Bisneto, J. J. C. . & Ansell, S. M., 2016, In : F1000Research. 5, 768.Research output: Contribution to journal › Review article
4
Scopus
citations
Targeting the PD-1 pathway in patients with relapsed classic Hodgkin lymphoma following allogeneic stem cell transplant is safe and effective
Villasboas Bisneto, J. J. C. ., Ansell, S. M. & Witzig, T. E., Mar 15 2016, In : Oncotarget. 7, 11, p. 13260-13264 5 p.Research output: Contribution to journal › Article
44
Scopus
citations
The use of pembrolizumab for the treatment of metastatic uveal melanoma
Kottschade, L. A., Mc Williams, R. R., Markovic, S. N., Block, M. S., Villasboas Bisneto, J. J. C. ., Pham, A. Q., Esplin, B. L. & Dronca, R. S., Feb 4 2016, (Accepted/In press) In : Melanoma Research.Research output: Contribution to journal › Article
50
Scopus
citations
Transition of care for inpatient hematology patients receiving chemotherapy: Development of hospital discharge huddle process and effects of implementation
Warsame, R., Kasi, P. M., Villasboas Bisneto, J. J. C. ., Gallenberg, D., Wolf, R., Ward, J., Matt-Hensrud, N., Grethen, K., Colborn, L., Zeldenrust, S., Lacy, M. & Thompson, C. A., Jan 1 2016, In : Journal of Oncology Practice. 12, 1, p. e88-e94Research output: Contribution to journal › Article
4
Scopus
citations
2015
Pseudomyxoma pleuri a rare manifestation of an uncommon disease
Del Valle Somiedo Gutiérrez, M., Villasboas Bisneto, J. J. C. ., Lee, C. U., Johnson, G. B., Shen, R. K. & Maldonado, F., Jun 1 2015, In : American Journal of Respiratory and Critical Care Medicine. 191, 11, p. 1334-1335 2 p.Research output: Contribution to journal › Article
The era of immuno-oncology: are we there yet?
Villasboas Bisneto, J. J. C. . & Ansell, S. M., Mar 1 2015, In : Oncology (Williston Park, N.Y.). 29, 3, p. 204-205 2 p.Research output: Contribution to journal › Comment/debate
The era of immuno-oncology: Are we there yet?
Villasboas, J. C. & Ansell, S. M., Mar 15 2015, In : ONCOLOGY (United States). 29, 3Research output: Contribution to journal › Article
Therapeutic targets and investigated strategies for treating B-cell non-Hodgkin lymphoma
Villasboas Bisneto, J. J. C. . & Ansell, S. M., Aug 1 2015, In : Expert Opinion on Orphan Drugs. 3, 8, p. 921-932 12 p.Research output: Contribution to journal › Article